Citations

Clear

2960 citation(s) found for "Kim, P".

Quality of Care in Non–Small-Cell Lung Cancer: Findings From 11 Oncology Practices in Florida
Corman, M., Lee, Ji‐Hyun , Fulp, William J. , Schreiber, Fred, Brown, R. H. , Levine, Richard M., Cartwright, Thomas H. , Abesada‐Terk, Guillermo, Kim, George P., Alemany, Carlos, Faig, Douglas, Sharp, Philip, Markham, Merry Jennifer , Bepler, Gerold , Siegel, Erin M. , Shibata, David , Malafa, Mokenge P. , Jacobsen, Paul B. , Tanvetyanon, Tawee , Markham, Merry J

Mayo Clinic

Journal of Oncology Practice | November 16, 2011 | Volume: 7 | Issue: 6 | Pages: e25-e31

10.1200/jop.2011.000228 | PMID 22379428 Get It

On the basis of this data set of participating institutions in Florida, several areas in the care of patients with non–small-cell lung cancer were identified as targets for future quality improvement efforts.
A yeast functional screen predicts new candidate ALS disease genes
Couthouis, Julien , Hart, Michael P. , Shorter, James , DeJesus‐Hernandez, Mariely, Erion, Renske, Oristano, Rachel, Liu, Annie X., Ramos, Daniel M. , Jethava, Niti, Hosangadi, Divya, Epstein, James, Chiang, Ashley, Diaz, Zamia, Nakaya, Tadashi , Ibrahim, Fadia , Kim, Hyung‐Jun , Solski, Jennifer A., Williams, Kelly L. , Mojsilovic‐Petrovic, Jelena , Ingre, Caroline , Graff‐Radford, Neill R. , Dickson, Dennis W. , Clay-Falcone, Dana, Elman, Lauren , McCluskey, Leo, Greene, Robert A., Kalb, Robert G. , Trojanowski, John Q. , Ludolph, Albert C. , Robberecht, Wim, Nicholson, Garth A. , Blair, Ian P. , King, Oliver D. , Rademakers, Rosa , Mourelatos, Zissimos P. , Gitler, Aaron D. , Fifita, Jennifer A. , Epstein, James, Boylan, Khrista , Lee, Virginia M.‐Y. , Andersen, Peter Munch , Bonini, Nancy M. , Deerlin, Vivianna M. Van , Dickson, Dennis W , Gitler, Aaron D , Shorter, James

Mayo Clinic

Proceedings of the National Academy of Sciences | November 8, 2011 | Volume: 108 | Issue: 52 | Pages: 20881-20890

10.1073/pnas.1109434108 | PMID 22065782 Get It

Amyotrophic lateral sclerosis (ALS) is a devastating and universally fatal neurodegenerative disease. Mutations in two related RNA-binding proteins, TDP-43 and FUS, that harbor prion-like domains, cause some forms of ALS. There are at least 213 human proteins harboring RNA recognition motifs, including FUS and TDP-43, raising the possibility that additional RNA-binding proteins might contribute to ALS pathogenesis. We performed a systematic survey of these proteins to find additional candidates similar to TDP-43 and FUS, followed by bioinformatics to predict prion-like domains in a subset of them. We sequenced one of these genes, TAF15 , in patients with ALS and identified missense variants, which were absent in a large number of healthy controls. These disease-associated variants of TAF15 caused formation of cytoplasmic foci when expressed in primary cultures of spinal cord neurons. Very similar to TDP-43 and FUS, TAF15 aggregated in vitro and conferred neurodegeneration in Drosophila , with the ALS-linked variants having a more severe effect than wild type. Immunohistochemistry of postmortem spinal cord tissue revealed mislocalization of TAF15 in motor neurons of patients with ALS. We propose that aggregation-prone RNA-binding proteins might contribute very broadly to ALS pathogenesis and the genes identified in our yeast functional screen, coupled with prion-like domain prediction analysis, now provide a powerful resource to facilitate ALS disease gene discovery.
Genes Associated with Recurrence of Hepatocellular Carcinoma: Integrated Analysis by Gene Expression and Methylation Profiling
Yang, Ju Dong , Seol, So‐Young, Leem, Sun-Hee, Kim, Yong‐Hoon , Sun, Zhifu , Lee, Ju‐Seog , Thorgeirsson, Snorri S., Chu, In‐Sun , Roberts, Lewis R. , Kang, Koo Jeong , Yang, Ju Dong , Roberts, Lewis R , Sun, Zhifu

Mayo Clinic

Journal of Korean Medical Science | November 1, 2011 | Volume: 26 | Issue: 11 | Pages: 1428

10.3346/jkms.2011.26.11.1428 | PMID 22065898 Get It

miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
Park, Jong Kook , Kogure, Takayuki , Nuovo, Gerard J., Jiang, Jinmai , He, Lei , Kim, Ji Hye , Phelps, Mitch A. , Papenfuss, Tracey L. , Schmittgen, Thomas D. , Croce, Carlo Maria , Patel, Tushar , Phelps, Mitch

Mayo Clinic

Cancer Research | October 18, 2011 | Volume: 71 | Issue: 24 | Pages: 7608-7616

10.1158/0008-5472.can-11-1144 | PMID 22009537 Get It

Abstract Patients with advanced hepatocellular carcinoma (HCC) face a dismal prognosis because of a lack of any effective therapies. To address this situation, we conducted a preclinical investigation of the therapeutic efficacy of oligonucleotides directed against the oncogenic microRNA miR-221, which has been implicated in HCC. Of 9 chemistries evaluated, we determined that a 2′-O-methyl phosphorothioate-modified anti-miR-221 oligonucleotide was most effective at reducing proliferation in vitro. A cholesterol-modified isoform of anti-miR-221 (chol-anti-miR-221) exhibited improved pharmacokinetics and liver tissue distribution compared with unmodified oligonucleotide. Chol-anti-miR-221 significantly reduced miR-221 levels in liver within a week of intravenous administration and in situ hybridization studies confirmed accumulation of the oligonucleotide in tumor cells in vivo. Within the same period, chol-anti-miR-221 reduced tumor cell proliferation and increased markers of apoptosis and cell-cycle arrest, elevating the tumor doubling time and increasing mouse survival. Taken together, our findings offer a preclinical proof of efficacy for chol-anti-miR-221 in a valid orthotopic mouse model of HCC, suggesting that this targeted agent could benefit treatment for patients with advanced HCC. Cancer Res; 71(24); 7608–16. ©2011 AACR.
Comparison of Transthoracic Echocardiography With N-Terminal Pro-Brain Natriuretic Peptide as a Tool for Risk Stratification of Patients Undergoing Major Noncardiac Surgery
Chang, Sung‐A , Choi, Jin-Oh, Lee, Sang‐Cheol , Park, Seung Woo , Oh, Jae K. , Kim, Duk‐Kyung , Jeon, Eun‐Seok , Park, Sung‐Ji , Choi, Jin‐Ho , Cho, Soo‐Jin

Mayo Clinic

Korean Circulation Journal | October 13, 2011 | Volume: 41 | Issue: 9 | Pages: 505

10.4070/kcj.2011.41.9.505 | PMID 22022325 Get It

Effect of public deliberation on attitudes toward surrogate consent for dementia research
Kim, Scott Y. H. , Kim, H.M., Vries, Raymond De , Damschroder, Laura J. , Appelbaum, Paul S. , Kim, Hyungjin Myra , Knopman, David S. , Appelbaum, Paul

Mayo Clinic

Neurology | October 6, 2011 | Volume: 77 | Issue: 24 | Pages: 2097-2104

10.1212/wnl.0b013e31823648cb | PMID 21975207 Get It

Cardiac Magnetic Resonance Imaging Pericardial Late Gadolinium Enhancement and Elevated Inflammatory Markers Can Predict the Reversibility of Constrictive Pericarditis After Antiinflammatory Medical Therapy
Feng, DaLi, Glockner, James, Kim, Kyehun, Martinez, Matthew W. , Syed, Imran S., Araoz, Philip A. , Breen, Jerome F., Espinosa, Raúl E. , Sundt, Thoralf M. , Schaff, Hartzell V. , Oh, Jae K. , Schaff, Hartzell

Mayo Clinic

Circulation | October 4, 2011 | Volume: 124 | Issue: 17 | Pages: 1830-1837

10.1161/circulationaha.111.026070 | PMID 21969014 Get It

Background— Constrictive pericarditis (CP) is a disabling disease, and usually requires pericardiectomy to relieve heart failure. Reversible CP has been described, but there is no known method to predict the reversibility. Pericardial inflammation may be a marker for reversibility. As a pilot study, we assessed whether cardiac magnetic resonance imaging pericardial late gadolinium enhancement (LGE) and inflammatory biomarkers could predict the reversibility of CP after antiinflammatory therapy. Method and Results— Twenty-nine CP patients received antiinflammatory medications after cardiac magnetic resonance imaging. Fourteen patients had resolution of CP, whereas 15 patients had persistent CP after 13 months of follow-up. Baseline LGE pericardial thickness was greater in the group with reversible CP than in the persistent CP group (4±1 versus 2±1 mm, P =0.001). Qualitative intensity of pericardial LGE was moderate or severe in 93% of the group with reversible CP and in 33% of the persistent CP group ( P =0.002). Cardiac magnetic resonance imaging LGE pericardial thickness ≥3 mm had 86% sensitivity and 80% specificity to predict CP reversibility. The group with reversible CP also had higher baseline C-reactive protein and erythrocyte sedimentation rate than the persistent CP group (59±52 versus 12±14 mg/L, P =0.04 and 49±25 versus 15±16 mm/h, P =0.04, respectively). Antiinflammatory therapy was associated with a reduction in C-reactive protein, erythrocyte sedimentation rate, and pericardial LGE in the group with reversible CP but not in the persistent CP group. Conclusions— Reversible CP was associated with pericardial and systemic inflammation. Antiinflammatory therapy was associated with a reduction in pericardial and systemic inflammation and LGE pericardial thickness, with resolution of CP physiology and symptoms. Further studies in a larger number of patients are needed.
A Multidisciplinary Evaluation of Inter-Reviewer Agreement of the Nephrometry Score and the Prediction of Long-Term Outcomes
Weight, Christopher , Atwell, Thomas D. , Fazzio, Robert T. , Kim, Simon P. , Kenny, McCabe C., Lohse, Christine M. , Boorjian, Stephen A. , Leibovich, Bradley C. , Thompson, R. Houston

Mayo Clinic

Journal of Urology | September 29, 2011 | Volume: 186 | Issue: 4 | Pages: 1223-1228

10.1016/j.juro.2011.05.052 | PMID 21849200 Get It

Contemporary Trends in Nephrectomy for Renal Cell Carcinoma in the United States: Results From a Population Based Cohort
Kim, Simon P. , Shah, Nilay D. , Weight, Christopher , Thompson, R. Houston, Moriarty, James P. , Shippee, Nathan D. , Costello, Brian A. , Boorjian, Stephen A. , Leibovich, Bradley C. , Shippee, Nathan

Mayo Clinic

Journal of Urology | September 26, 2011 | Volume: 186 | Issue: 5 | Pages: 1779-1785

10.1016/j.juro.2011.07.041 | PMID 21944105 Get It

High-Performance 3D Compressive Sensing MRI Reconstruction Using Many-Core Architectures
Kim, Daehyun , Trzasko, Joshua D. , Smelyanskiy, Mikhail , Haider, Clifton R. , Dubey, Pradeep Kumar , Manduca, Armando

Mayo Clinic

International Journal of Biomedical Imaging | September 15, 2011 | Volume: 2011 | Issue: No issue available | Pages: 1-11

10.1155/2011/473128 | PMID 21922017 Get It

Compressive sensing (CS) describes how sparse signals can be accurately reconstructed from many fewer samples than required by the Nyquist criterion. Since MRI scan duration is proportional to the number of acquired samples, CS has been gaining significant attention in MRI. However, the computationally intensive nature of CS reconstructions has precluded their use in routine clinical practice. In this work, we investigate how different throughput-oriented architectures can benefit one CS algorithm and what levels of acceleration are feasible on different modern platforms. We demonstrate that a CUDA-based code running on an NVIDIA Tesla C2050 GPU can reconstruct a 256 × 160 × 80 volume from an 8-channel acquisition in 19 seconds, which is in itself a significant improvement over the state of the art. We then show that Intel's Knights Ferry can perform the same 3D MRI reconstruction in only 12 seconds, bringing CS methods even closer to clinical viability.